-+ 0.00%
-+ 0.00%
-+ 0.00%

MERCK & CO - TWO ADDITIONAL PHASE 3 TRIALS UNDERWAY FOR IFINATAMAB DERUXTECAN IN CRPC AND ESCC

路透·09/25/2026 20:30:22

请登录查看新闻详情